NEOPTERIN IN PEDIATRIC LIVING-DONOR LIVER TRANSPLANT PATIENT
https://doi.org/10.15825/1995-1191-2011-2-58-62
Abstract
Neopterin (NP) is a marker of macrophages activation and is used for monitoring rejection in patients after heart, renal transplantation. The aim of the study was to evaluate plasma levels of NP in children before and after living-donor liver transplantation (LDLT) and its relationship with the postoperative course. The study included 72 children with end-stage liver disease (ESLD), aged 17 ± 11 (4–28) months before and after LDLT, 15 healthy children aged 9.9 ± 5.7 (3–21) months and 38 adult living-related liver donors, aged 37 ± 19 (18–56) years.
In children with ESLD pre-transplant plasma levels of NP (25.2 ± 19.9 nmol/l) was significantly higher than in healthy donors or healthy children (5.5 ± 3.4 and 6.3 ± 2.7 nmol/l, resp., p < 0.01). After LDLT plasma level of NP was higher in children, who had graft dysfunction at days 28–32 (61.9 ± 30.9 nmol/l) after LDLT than in children who had no graft dysfunction (24.0 ± 5.6 nmol/l). The measurement of NP concentrations may be useful for monitoring of the postoperative course.
About the Authors
O. P. Shevchenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
G. A. Olefirenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
M. E. Pishchulina
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
I. E. Tsirulnikova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
N. Sh. Muratova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
O. M. Tsirulnikova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
S. V. Gautier
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
References
1. Готье С.В., Константинов В.А., Цирульникова О.М. Трансплантация печени. М.: Медицинское информа- ционное агентство, 2008. 246 с.
2. Готье С.В., Шевченко О.П. Новые лабораторные те- сты – новое в клинической трансплантологии // Лабо- раторная медицина в свете концепции развития здра- воохранения России до 2020 года. 2009. С. 82–94.
3. Насонов Е.Л. Современные направления иммуноло- гических исследований при хронических воспали- тельных и аутоиммунных заболеваниях человека // Тер. архив. 2001. No 8. С. 43–46.
4. Орлова О.В., Казаков Э.Н., Кормер А.Я. и др. Клинико-диагностическое и прогностическое зна- чение неоптерина и С-реактивного белка при цито- мегаловирусной пневмонии у пациента после транс- плантации сердца // Вестник трансплантологии и ис- кусственных органов. 2004. No 2. С. 13–17.
5. Шумаков В.И., Хубутия М.Ш., Шевченко О.П. и др. Гуморальное отторжение пересаженного сердца: корреляция уровней неоптерина с результатами им- муногистохимических исследований // Вестник трансплантологии и искусственных органов. 2003. No 1. С. 3–9.
6. Шевченко О.П., Олефиренко Г.А., Орлова О.В. Алго- ритм дифференцирования инфекционных осложне- ний и острого отторжения у реципиентов сердца // Инфекции в трансплантологии / Под ред. С.В. Готье. Тверь: Триада, 2010. С. 177–212.
7. Desai M., Neuberger J. Chronic Liver allograft rejec- tion // Transplant. Proc. 2009. Vol. 41. P. 773–776.
8. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance // Ann N Y Acad Sci. 2004 Jun. Vol. 1024. P. 138–146.
9. Havel M., Laczkovics A., Teufelsbauer H. et al. Neopterin as a new marker to detect acute rejection after heart transplantation // J. Heart Transplant. 1989. Vol. 8. P. 167–170.
10. Ilknur K., Demir M., Cevahir N. et al. Serum neopte- rin levels in patients with replicative and nonreplicative HBV carriers BCM Infectious Diseases. 2006. Vol. 6. P. 157.
11. Konigsrainer A., Reibnegger G., Ofner D. et al. Pancrea- tic juice neopterin excretion: reliable marker for detec- tion of pancreatic allograft rejection // Transplant. Proc. 1990. Vol. 22. P. 671–672.
12. Melichar, Bohuslav, John J. et al. Intraperitoneal flu- id neopterin, nitrate, and tryptophan after regional ad- ministration of interleukin-12 immunotherapy. 2003. Vol. 26 (3). P. 270–276.
13. Muller T.F., Trosch F., Ebel H. et al. Pancreas-specific protein, serum amyloid A and neopterin in the diagno- sis of rejection after simultaneous pancreas and kid- ney transplantation // Transp. Int. 1997. Vol. 10 (3). P. 185–191.
14. Weimer R., Süsal C., Yildiz S. et al. Post-transplant sCD30 and neopterin as predictor of chronic allograft nephropathy: impact of different immunosuppressive regimens // Transplantation. 2006. Vol. 6. P. 1865– 1847.
Review
For citations:
Shevchenko O.P., Olefirenko G.A., Pishchulina M.E., Tsirulnikova I.E., Muratova N.Sh., Tsirulnikova O.M., Gautier S.V. NEOPTERIN IN PEDIATRIC LIVING-DONOR LIVER TRANSPLANT PATIENT. Russian Journal of Transplantology and Artificial Organs. 2011;13(2):58-62. (In Russ.) https://doi.org/10.15825/1995-1191-2011-2-58-62
Views:
929
Email this article 